Company Overview

Update
Status:
Acquired by Mallinckrodt
Founded:
2004
Headquarters:
San Diego, CA
IPO:
Went Public on Oct 25, 2006
Stock:
CADX
Categories:
Biotechnology
Description:
Biopharmaceutical company

Detailed Description

Update

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 2010 Cadence resubmitted a New Drug Application for its investigational product candidate, OFIRMEVTM (acetaminophen) injection for the treatment of pain and fever in adults and children. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date for OFIRMEV of November 4, 2010.

Current Team (3)

Update

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • Headquarters

    12481 High Bluff Drive

    Suite 200

    San Diego, CA 92130

    USA

Images (1)

Update
  • 314ded177656f8c1f4b300f2378e4b2f